1. Home
  2. ICCM vs AFMD Comparison

ICCM vs AFMD Comparison

Compare ICCM & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCM
  • AFMD
  • Stock Information
  • Founded
  • ICCM 2006
  • AFMD 2000
  • Country
  • ICCM Israel
  • AFMD Germany
  • Employees
  • ICCM N/A
  • AFMD N/A
  • Industry
  • ICCM
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • ICCM
  • AFMD Health Care
  • Exchange
  • ICCM Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • ICCM 45.5M
  • AFMD 45.6M
  • IPO Year
  • ICCM N/A
  • AFMD 2014
  • Fundamental
  • Price
  • ICCM $1.12
  • AFMD $1.19
  • Analyst Decision
  • ICCM Strong Buy
  • AFMD Strong Buy
  • Analyst Count
  • ICCM 2
  • AFMD 5
  • Target Price
  • ICCM $2.70
  • AFMD $13.50
  • AVG Volume (30 Days)
  • ICCM 646.4K
  • AFMD 559.0K
  • Earning Date
  • ICCM 11-26-2024
  • AFMD 11-14-2024
  • Dividend Yield
  • ICCM N/A
  • AFMD N/A
  • EPS Growth
  • ICCM N/A
  • AFMD N/A
  • EPS
  • ICCM N/A
  • AFMD N/A
  • Revenue
  • ICCM $3,671,000.00
  • AFMD $6,287,085.00
  • Revenue This Year
  • ICCM $18.61
  • AFMD N/A
  • Revenue Next Year
  • ICCM $54.91
  • AFMD $28.44
  • P/E Ratio
  • ICCM N/A
  • AFMD N/A
  • Revenue Growth
  • ICCM 26.02
  • AFMD N/A
  • 52 Week Low
  • ICCM $0.48
  • AFMD $1.14
  • 52 Week High
  • ICCM $1.57
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • ICCM 75.27
  • AFMD 14.28
  • Support Level
  • ICCM $0.79
  • AFMD $2.02
  • Resistance Level
  • ICCM $1.19
  • AFMD $2.21
  • Average True Range (ATR)
  • ICCM 0.08
  • AFMD 0.26
  • MACD
  • ICCM 0.03
  • AFMD -0.11
  • Stochastic Oscillator
  • ICCM 84.44
  • AFMD 2.76

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: